血液製剤の世界市場レポート 2025年

血液製剤市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.8%で665億9,000万米ドルに成長します。予測期間の成長は、血液成分に対する需要の高まり、個別化医療へのアプローチ、新たな治療法やアプリケーション、世界のヘルスケアインフラ開発に起因しています。予測期間の主な動向には、血液処理システムの自動化と統合化、病原体低減血液成分の需要、血液成分のカスタマイズと個別化、血小板豊富血漿（PRP）と血小板豊富フィブリン（PRF）への注目、規制遵守と厳格な品質基準などがあります。

世界の献血の増加は、血液製剤市場の成長を促進します。献血は、医療用に血液を提供する利他的な行為であり、手術、がん治療、慢性疾患、外傷治療において重要な輸血を通じて生命を維持します。このプロセスにより、準備中いつでもどこでも必要なときに血液を確保することができます。例えば、国立血液サービス・ガーナは、2020年の156,453単位から2021年には173,938単位へと、採血量の増加を報告しています。さらに、世界銀行のデータによると、2020年6月から2021年6月にかけての採血量は86％急増し、186,239単位に達し、214,187人以上に対応しました。したがって、献血の増加は血液製剤市場の成長を促進します。

血液関連疾患の増加が血液製剤市場を押し上げると予測されています。これらの疾患には、血液成分、機能、凝固能力に影響を与える血液がんなどの多様な状態が含まれ、しばしば輸血や専門的な治療が必要となります。血液凝固因子、赤血球、血小板の欠乏が血液製剤の必要性を高めています。例えば、Blood Cancer UKによると、英国では年間約41,000人が血液がんの診断を受けており、現在約250,000人がこの症状を患っているといいます。統計によれば、生涯のうちに血液がんを発症する可能性は、男性で16人に1人、女性で22人に1人です。したがって、血液関連疾患の有病率の増加が血液製剤市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の血液製剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血液製剤市場：成長率分析
• 世界の血液製剤市場の実績：規模と成長, 2019-2024
• 世界の血液製剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界の血液製剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血液製剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全血
• 血液成分
• 血液製剤
• 世界の血液製剤市場抗血栓薬および抗凝固薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血小板凝集抑制剤
• 線維素溶解薬
• 抗凝固剤
• 世界の血液製剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 輸血
• 診断
• 調査
• 世界の血液製剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 血液銀行
• その他のエンドユーザー
• 世界の血液製剤市場全血の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新鮮な全血
• 保存された全血
• 世界の血液製剤市場血液成分の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 赤血球（RBC）
• 血小板
• プラズマ
• 白血球（WBC）
• 世界の血液製剤市場、血液製剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫グロブリン
• 凝固因子
• アルブミン
• フィブリノーゲン

第7章 地域別・国別分析

• 世界の血液製剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血液製剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血液製剤市場：競合情勢
• 血液製剤市場：企業プロファイル
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi Overview, Products and Services, Strategy and Financial Analysis
  • LEO Pharma A/S Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Portola Pharmaceuticals Inc.
• GlaxoSmithKline PLC
• Bayer AG
• Boehringer Ingelheim
• Celgene Corp
• Shandong East Chemical Industry Co.
• Xiamen Hisunny Chemical Co. LTD
• Merck & Co.
• Amgen Inc.
• Takeda Pharmaceutical Company Limited
• Novartis AG
• Johnson & Johnson
• Gilead Sciences Inc.
• Regeneron Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血液製剤市場2029：新たな機会を提供する国
• 血液製剤市場2029：新たな機会を提供するセグメント
• 血液製剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Blood preparation encompasses the comprehensive process of gathering, processing, and preserving blood and its components for utilization in transfusions or various medical treatments. This intricate procedure involves several stages such as donor screening, blood collection, testing, storage, and eventual transfusion.

The primary categories of blood preparation products include whole blood, blood components, and blood derivatives. Whole blood signifies blood that hasn't been separated into its individual constituents such as red blood cells, white blood cells, and plasma. It contains various antithrombotic and anticoagulant elements, including platelet aggregation inhibitors, fibrinolytics, and anticoagulants, which find applications in transfusions, diagnostics, and research purposes. Key end-users of these blood preparation products encompass hospitals, clinics, blood banks, and other medical facilities involved in managing and administering transfusions and medical treatments requiring blood and its components.

The blood preparation market research report is one of a series of new reports from The Business Research Company that provides blood preparation market statistics, including blood preparation industry global market size, regional shares, competitors with a blood preparation market share, detailed blood preparation market segments, market trends and opportunities, and any further data you may need to thrive in the blood preparation industry. This blood preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood preparation market size has grown strongly in recent years. It will grow from$48.03 billion in 2024 to $51.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in blood transfusion procedures, increasing prevalence of blood disorders, growing awareness of blood safety, global initiatives for blood donation, government regulations and standards

The blood preparation market size is expected to see strong growth in the next few years. It will grow to $66.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for blood components, personalized medicine approaches, emerging therapies and applications, global healthcare infrastructure development. Major trends in the forecast period include automation and integration of blood processing systems, demand for pathogen-reduced blood components, customization and personalization in blood components, focus on platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), regulatory compliance and stringent quality standards.

The increasing global blood donations are set to drive the growth of the blood preparation market. Blood donation involves the altruistic act of contributing blood for medical use, sustaining life through transfusions crucial in surgeries, cancer treatment, chronic illnesses, and trauma care. This process ensures the availability of blood whenever and wherever needed during preparation. For example, National Blood Service Ghana reported a rise in blood collections, from 156,453 units in 2020 to 173,938 units in 2021. Additionally, World Bank data indicated an 86% surge in blood collections from June 2020 to June 2021, reaching 186,239 units, catering to over 214,187 individuals. Therefore, the increase in blood donations propels the blood preparation market's growth.

The rise in blood-related disorders is anticipated to boost the blood preparation market. These disorders encompass diverse conditions such as blood cancers that impact blood components, functions, or clotting abilities, often necessitating transfusions or specialized treatments. Instances of deficiencies in clotting factors, red blood cells, or platelets drive the need for blood preparation. For instance, Blood Cancer UK revealed that around 41,000 individuals receive blood cancer diagnoses annually in the UK, with approximately 250,000 currently living with this condition. Statistics indicate a one in 16 men and one in 22 women likelihood of developing blood cancer during their lifetime. Hence, the increasing prevalence of blood-related disorders fuels the blood preparation market's growth.

Technological advancements are emerging as a significant trend in the blood preparation market. Leading companies in this sector are concentrating on developing innovative technological solutions to maintain their competitive edge. For instance, in June 2024, Innobiochips, a biotechnology company based in France, launched Omnys, an advanced blood grouping and testing solution designed to enhance the efficiency and precision of blood transfusion processes. Utilizing patented multiplex technologies, Omnys allows for high-resolution testing of various blood components, including ABO/D typing, phenotyping, extended phenotyping, and antibody screening. This all-in-one system integrates testing devices, reagents, and consumables to optimize workflows, enabling healthcare facilities and laboratories to conduct accurate blood analyses with minimal sample volumes.

Major players in the blood preparation market focus on product innovation, exemplified by advanced blood sampling kits, to improve accuracy and efficiency in blood collection processes. These kits streamline and enhance blood sample collection for diagnostic purposes. Capitainer, in December 2022, launched an upgraded self-sampling blood card collecting a larger volume (2 x 50 microliters), facilitating the measurement of additional biomarkers and enabling a broader range of analyses due to the increased blood quantity for accurate testing of specific substances. This innovation significantly enhances accuracy and ease in blood collection processes.

In October 2022, Pfizer Inc., a pharmaceutical and biotechnology company based in the U.S., acquired Global Blood Therapeutics for $5.4 billion. This acquisition aims to strengthen Pfizer's portfolio in treating sickle cell disease and to meet the critical needs of an underserved patient population. Global Blood Therapeutics Inc. is a U.S.-based biopharmaceutical company that primarily focuses on developing therapies for blood-related disorders, with a particular emphasis on sickle cell disease.

Major companies operating in the blood preparation market include AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation

North America was the largest region in the blood preparation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in the blood preparation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The blood preparation market consists of revenues earned by entities by providing services such as blood processing, blood storing, and distributing blood and blood components for transfusion services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood preparation market also includes sales of red cells, platelets, cryoprecipitated AHF (CRYO), and granulocytes, which are used in providing blood preparation services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Preparation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood preparation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood preparation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood preparation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Whole Blood; Blood Components; Blood Derivatives
• 2) By Antithrombotic And Anticoagulants Type: Platelet Aggregation Inhibitors; Fibrinolytics; Anticoagulants
• 3) By Application: Transfusion; Diagnostics; Research
• 4) By End User: Hospitals; Clinics; Blood Banks; Other End-Users
• Subsegments:
• 1) By Whole Blood: Fresh Whole Blood; Stored Whole Blood
• 2) By Blood Components: Red Blood Cells (RBC); Platelets; Plasma; White Blood Cells (WBC)
• 3) By Blood Derivatives: Immunoglobulins; Coagulation Factors; Albumin; Fibrinogen
• Companies Mentioned: AstraZeneca PLC; Sanofi; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Preparation Market Characteristics

3. Blood Preparation Market Trends And Strategies

4. Blood Preparation Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Blood Preparation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Preparation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Preparation Market Growth Rate Analysis
• 5.4. Global Blood Preparation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Preparation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Preparation Total Addressable Market (TAM)

6. Blood Preparation Market Segmentation

• 6.1. Global Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Blood
• Blood Components
• Blood Derivatives
• 6.2. Global Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platelet Aggregation Inhibitors
• Fibrinolytics
• Anticoagulants
• 6.3. Global Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transfusion
• Diagnostics
• Research
• 6.4. Global Blood Preparation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Blood Banks
• Other End-Users
• 6.5. Global Blood Preparation Market, Sub-Segmentation Of Whole Blood, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fresh Whole Blood
• Stored Whole Blood
• 6.6. Global Blood Preparation Market, Sub-Segmentation Of Blood Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Red Blood Cells (RBC)
• Platelets
• Plasma
• White Blood Cells (WBC)
• 6.7. Global Blood Preparation Market, Sub-Segmentation Of Blood Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoglobulins
• Coagulation Factors
• Albumin
• Fibrinogen

7. Blood Preparation Market Regional And Country Analysis

• 7.1. Global Blood Preparation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Preparation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Preparation Market

• 8.1. Asia-Pacific Blood Preparation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Preparation Market

• 9.1. China Blood Preparation Market Overview
• 9.2. China Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Preparation Market

• 10.1. India Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Preparation Market

• 11.1. Japan Blood Preparation Market Overview
• 11.2. Japan Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Preparation Market

• 12.1. Australia Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Preparation Market

• 13.1. Indonesia Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Preparation Market

• 14.1. South Korea Blood Preparation Market Overview
• 14.2. South Korea Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Preparation Market

• 15.1. Western Europe Blood Preparation Market Overview
• 15.2. Western Europe Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Preparation Market

• 16.1. UK Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Preparation Market

• 17.1. Germany Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Preparation Market

• 18.1. France Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Preparation Market

• 19.1. Italy Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Preparation Market

• 20.1. Spain Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Preparation Market

• 21.1. Eastern Europe Blood Preparation Market Overview
• 21.2. Eastern Europe Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Preparation Market

• 22.1. Russia Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Preparation Market

• 23.1. North America Blood Preparation Market Overview
• 23.2. North America Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Preparation Market

• 24.1. USA Blood Preparation Market Overview
• 24.2. USA Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Preparation Market

• 25.1. Canada Blood Preparation Market Overview
• 25.2. Canada Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Preparation Market

• 26.1. South America Blood Preparation Market Overview
• 26.2. South America Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Preparation Market

• 27.1. Brazil Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Preparation Market

• 28.1. Middle East Blood Preparation Market Overview
• 28.2. Middle East Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Preparation Market

• 29.1. Africa Blood Preparation Market Overview
• 29.2. Africa Blood Preparation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Preparation Market, Segmentation By Antithrombotic And Anticoagulants Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Preparation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Preparation Market Competitive Landscape And Company Profiles

• 30.1. Blood Preparation Market Competitive Landscape
• 30.2. Blood Preparation Market Company Profiles
  • 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. LEO Pharma A/S Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Blood Preparation Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Portola Pharmaceuticals Inc.
• 31.3. GlaxoSmithKline PLC
• 31.4. Bayer AG
• 31.5. Boehringer Ingelheim
• 31.6. Celgene Corp
• 31.7. Shandong East Chemical Industry Co.
• 31.8. Xiamen Hisunny Chemical Co. LTD
• 31.9. Merck & Co.
• 31.10. Amgen Inc.
• 31.11. Takeda Pharmaceutical Company Limited
• 31.12. Novartis AG
• 31.13. Johnson & Johnson
• 31.14. Gilead Sciences Inc.
• 31.15. Regeneron Pharmaceuticals Inc.

32. Global Blood Preparation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Preparation Market

34. Recent Developments In The Blood Preparation Market

35. Blood Preparation Market High Potential Countries, Segments and Strategies

• 35.1 Blood Preparation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Preparation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Preparation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer